Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn’s disease in Argentina, Brazil, Colombia, and Mexico-Reference-Cited by-同舟云学术

Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn’s disease in Argentina, Brazil, Colombia, and Mexico

Published:2016-07-19 Issue:12 Volume:19 Page:1187-1199
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Tundia Namita¹,Kotze Paulo Gustavo²,Rojas Serrano Jorge³,Mendes de Abreu Mirhelen⁴,Skup Martha¹,Macaulay Dendy⁵,Signorovitch James⁵,Chaves Leonardo¹,Chao Jingdong¹,Bao Yanjun¹

Affiliation:

1. AbbVie Inc., North Chicago, IL, USA;

2. Catholic University of Paraná, Curitiba, Brazil;

3. National Autonomous University of Mexico, Mexico City, Mexico;

4. Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;

5. Analysis Group, New York, NY, USA

Funder

AbbVie

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2016.1209508

Reference79 articles.

1. Challenges in the management of rheumatoid arthritis in developing countries

2. Bloomberg School of Public Health, Johns Hopkins University. Noncommunicable chronic diseases in Latin America and the Caribbean. Buenos Aires, Argentina: The Healthy Caribbean Coalition Website; 2009. http://www.healthycaribbean.org/publications/documents/NCD-in-LAC-USAID.pdf. Accessed April 10, 2015

3. Current therapies in rheumatoid arthritis: A Latin American perspective

4. Management of Crohn's Disease in Adults

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina;Revista Peruana de Medicina Experimental y Salud Pública;2024-06-21

2. Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian public health system;Revista de Saúde Pública;2023-07-19

3. Intestinal complications in patients with Crohn’s disease in the Brazilian public healthcare system between 2011 and 2020;World Journal of Clinical Cases;2023-05-16

4. IBD barriers across the continents: a continent-specific analysis: Latin America;Therapeutic Advances in Gastroenterology;2023-01

5. Safety of biological therapy in patients with rheumatoid arthritis in administrative health databases: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-08-11